Rockwell Medical Inc (RMTI)
1.49
+0.01
(+0.68%)
USD |
NASDAQ |
Apr 18, 16:00
Rockwell Medical Cash from Operations (TTM): -9.412M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -9.412M |
| September 30, 2023 | -9.481M |
| June 30, 2023 | -6.83M |
| March 31, 2023 | -10.99M |
| December 31, 2022 | -16.93M |
| September 30, 2022 | -25.84M |
| June 30, 2022 | -31.82M |
| March 31, 2022 | -30.85M |
| December 31, 2021 | -33.53M |
| September 30, 2021 | -33.08M |
| June 30, 2021 | -30.92M |
| March 31, 2021 | -35.60M |
| December 31, 2020 | -29.64M |
| September 30, 2020 | -26.37M |
| June 30, 2020 | -27.63M |
| March 31, 2020 | -28.37M |
| December 31, 2019 | -27.25M |
| September 30, 2019 | -27.74M |
| June 30, 2019 | -26.34M |
| March 31, 2019 | -21.24M |
| December 31, 2018 | -20.42M |
| September 30, 2018 | -19.45M |
| June 30, 2018 | -18.85M |
| March 31, 2018 | -20.64M |
| December 31, 2017 | -21.11M |
| Date | Value |
|---|---|
| September 30, 2017 | -15.76M |
| June 30, 2017 | -18.28M |
| March 31, 2017 | -16.46M |
| December 31, 2016 | -12.45M |
| September 30, 2016 | -12.78M |
| June 30, 2016 | -9.920M |
| March 31, 2016 | -11.08M |
| December 31, 2015 | -13.33M |
| September 30, 2015 | 4.016M |
| June 30, 2015 | 8.167M |
| March 31, 2015 | 11.31M |
| December 31, 2014 | 4.258M |
| September 30, 2014 | -21.44M |
| June 30, 2014 | -31.44M |
| March 31, 2014 | -49.72M |
| December 31, 2013 | -50.66M |
| September 30, 2013 | -49.69M |
| June 30, 2013 | -48.80M |
| March 31, 2013 | -33.75M |
| December 31, 2012 | -30.75M |
| September 30, 2012 | -27.11M |
| June 30, 2012 | -20.61M |
| March 31, 2012 | -14.52M |
| December 31, 2011 | -10.78M |
| September 30, 2011 | -6.421M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-35.60M
Minimum
Mar 2021
-6.83M
Maximum
Jun 2023
-24.66M
Average
-27.63M
Median
Jun 2020
Cash from Operations (TTM) Benchmarks
| Cyclacel Pharmaceuticals Inc | -16.11M |
| Oragenics Inc | -7.291M |
| Alpine Immune Sciences Inc | -79.01M |
| Corvus Pharmaceuticals Inc | -23.94M |
| MAIA Biotechnology Inc | -13.07M |